EYPT

Paggiarino Dario A.

Known title: Chief Medical OfficerCIK: 0001574261

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Yahoo article highlights EYPT as a potential portfolio addition. A recent Yahoo article discussed EyePoint Inc. (EYPT) and listed reasons why the stock could be considered for a portfolio. The piece referenced the company's analyst consensus target of $25.91 and its 52‑week range of $2.93 to $19.11. The article’s positive tone adds to current market conversation around the stock.

this person other insiders at EYPT

Transaction History

EYPT▲ Buy$0
EYPT▼ Sell$61K
EYPT▼ Sell$147K
EYPT▲ Buy$0
EYPT▲ Buy$0
EYPT▼ Sell$320K
EYPT▼ Sell$73K
EYPT▼ Sell$74K
EYPT▲ Buy$0
EYPT▲ Buy$0
EYPT▲ Buy$201K
EYPT▲ Buy$442K
EYPT▼ Sell$1K
EYPT▼ Sell$868K
EYPT▼ Sell$397K
EYPT▲ Buy$670
EYPT▲ Buy$4K
EYPT▼ Sell$8K
EYPT▼ Sell$8K
EYPT▲ Buy$4K
EYPT▲ Buy$73K
EYPT▲ Buy$74K
EYPT▼ Sell$141K
EYPT▼ Sell$140K
EYPT▼ Sell$77K
EYPT▲ Buy$26K
EYPT▼ Sell$51K
EYPT▲ Buy$41K
EYPT▲ Buy$75K
EYPT▼ Sell$484K
EYPT▲ Buy$0
EYPT▼ Sell$92K
EYPT▼ Sell$29K
EYPT▲ Buy$15K
EYPT▲ Buy$310K
EYPT▼ Sell$674K
EYPT▲ Buy$0
EYPT▲ Buy$0
EYPT▼ Sell$8K
EYPT▼ Sell$7K
EYPT▼ Sell$13K
EYPT▲ Buy$0
EYPT▼ Sell$17K
EYPT▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.